838
Participants
Start Date
October 13, 2017
Primary Completion Date
October 2, 2018
Study Completion Date
May 29, 2019
Fremanezumab
Fremanezumab will be administered per dose and schedule specified in the arm.
Placebo
Placebo matching to fremanezumab will be administered per schedule specified in the arm.
Teva Investigational Site 37089, Brussels
Teva Investigational Site 39048, Glostrup Municipality
Teva Investigational Site 39052, Ballerup Municipality
Teva Investigational Site 45016, Bern
Teva Investigational Site 37091, Hasselt
Teva Investigational Site 37090, Liège
Teva Investigational Site 45018, Bad Zurzach
Teva Investigational Site 45017, Lugano
Teva Investigational Site 39050, Vejle
Teva Investigational Site 37092, Bruges
Teva Investigational Site 39049, Aarhus
Teva Investigational Site 39051, Aalborg
Teva Investigational Site 32697, Berlin
Teva Investigational Site 35235, Marseille
Teva Investigational Site 14753, Amherst
Teva Investigational Site 31230, Santiago de Compostela
Teva Investigational Site 32701, Rostock
Teva Investigational Site 40032, Turku
Teva Investigational Site 32698, Hamburg
Teva Investigational Site 40037, Turku
Teva Investigational Site 14747, Pikesville
Teva Investigational Site 32700, Kiel
Teva Investigational Site 14736, Greensboro
Teva Investigational Site 14741, Greensboro
Teva Investigational Site 14732, Raleigh
Teva Investigational Site 31235, Madrid
Teva Investigational Site 31236, Madrid
Teva Investigational Site 14760, Decatur
Teva Investigational Site 31226, Pamplona
Teva Investigational Site 14758, Maitland
Teva Investigational Site 14738, Orlando
Teva Investigational Site 14742, Huntsville
Teva Investigational Site 14743, Nashville
Teva Investigational Site 14745, Memphis
Teva Investigational Site 35236, Voiron
Teva Investigational Site 31229, Santander
Teva Investigational Site 14735, Louisville
Teva Investigational Site 31234, Seville
Teva Investigational Site 32694, Bochum
Teva Investigational Site 32699, Essen
Teva Investigational Site 31233, Valencia
Teva Investigational Site 31227, Valencia
Teva Investigational Site 31225, Valladolid
Teva Investigational Site 14731, Ann Arbor
Teva Investigational Site 31228, Zaragoza
Teva Investigational Site 30199, Florence
Teva Investigational Site 54157, Rychnov nad Kněžnou
Teva Investigational Site 54158, Pardubice
Teva Investigational Site 14748, Plymouth
Teva Investigational Site 35238, Lille
Teva Investigational Site 14740, Evanston
Teva Investigational Site 14730, Chicago
Teva Investigational Site 32695, Königstein im Taunus
Teva Investigational Site 35239, Strasbourg
Teva Investigational Site 14746, Omaha
Teva Investigational Site 35237, Bron
Teva Investigational Site 54159, Ostrava
Teva Investigational Site 32692, Göppingen
Teva Investigational Site 14733, Austin
Teva Investigational Site 14749, Colorado Springs
Teva Investigational Site 32689, München
Teva Investigational Site 14737, Meridian
Teva Investigational Site 14751, West Jordan
Teva Investigational Site 14752, Albuquerque
Teva Investigational Site 32693, Ulm
Teva Investigational Site 40036, Oulu
Teva Investigational Site 14843, Santa Monica
Teva Investigational Site 14729, Long Beach
Teva Investigational Site 14739, San Diego
Teva Investigational Site 14750, Fall River
Teva Investigational Site 14734, Watertown
Teva Investigational Site 14754, Berlin
Teva Investigational Site 14761, Lincoln
Teva Investigational Site 14756, Warwick
Teva Investigational Site 54162, Brno
Teva Investigational Site 54165, Ostrava-Moravska
Teva Investigational Site 54163, Prague
Teva Investigational Site 54161, Prague
Teva Investigational Site 54164, Prague
Teva Investigational Site 54160, Prague
Teva Investigational Site 54166, Prague
Teva Investigational Site 40034, Helsinki
Teva Investigational Site 40035, Helsinki
Teva Investigational Site 40033, Tampere
Teva Investigational Site 35240, Nice
Teva Investigational Site 32690, Berlin
Teva Investigational Site 32691, Halle
Teva Investigational Site 30204, Roma
Teva Investigational Site 38126, Amsterdam
Teva Investigational Site 38127, Blaricum
Teva Investigational Site 38124, Leiden
Teva Investigational Site 38125, Tilburg
Teva Investigational Site 53420, Krakow
Teva Investigational Site 53425, Krakow
Teva Investigational Site 53422, Lodz
Teva Investigational Site 53424, Lodz
Teva Investigational Site 53418, Lublin
Teva Investigational Site 53416, Poznan
Teva Investigational Site 53419, Szczecin
Teva Investigational Site 53417, Warsaw
Teva Investigational Site 53423, Warsaw
Teva Investigational Site 31231, Barcelona
Teva Investigational Site 42050, Helsingborg
Teva Investigational Site 42049, Huddinge
Teva Investigational Site 42051, Lund
Teva Investigational Site 42052, Stockholm
Teva Investigational Site 42054, Stockholm
Teva Investigational Site 34231, Glasgow
Teva Investigational Site 34232, Hull
Teva Investigational Site 34233, London
Teva Investigational Site 34230, Oxford
Teva Investigational Site 34235, Salford
Teva Investigational Site 34236, Stoke-on-Trent
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY